RowAnalytics' Giro Initiative Brings Precision Medicine Perspective to Neurodegenerative Disorders
RowAnalytics, the Martinos Center for Biomedical Imaging, and Envision Genomics are partnering on a new initiative called Giro Health, which they describe as an open initiative in precision medicine that seeks to improve diagnosis and personalize treatments for complex neurological and neurodegenerative diseases.
This breadth of data that RowAnalytics' platform can take in was a key factor in IBM's decision to work with the company to pair its software with IBM hardware, according to Janis Landry-Lane, a global sales executive for IBM's high-performance computing business. The two companies have a business relationship that allows them to co-sell RowAnalytics' platform with IBM hardware. Landry-Lane also played a key role in bringing together the partners of the GIRO Health initiative.
"They had a comprehensive approach to disease," she said. "They addressed the scale of analyzing large-population, multi-modal data and delivering the results for a comprehensive individual treatment plan. We found their approach unique, [and] we wanted to address the computing requirements for the complexity of their algorithms with the massive amount of data being analyzed."
Read full article using link above.